• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米力农对重度心力衰竭患者左心室功能及心肌收缩力的影响。

Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure.

作者信息

Sonnenblick E H, Grose R, Strain J, Zelcer A A, LeJemtel T H

出版信息

Circulation. 1986 Mar;73(3 Pt 2):III162-7.

PMID:3510772
Abstract

The potent vasodilating properties of the bipyridine derivatives confounds the assessment of changes in contractility as measured by peak positive left ventricular dP/dt and explains why the positive inotropic action of these agents has not been consistently demonstrated in patients with ventricular dysfunction. Therefore we studied the individual dose-response effects of intravenous milrinone on myocardial contractility as measured by peak positive left ventricular dP/dt in the context of concurrent changes in ventricular filling pressure. Incremental doses of milrinone caused a dose-related increase in peak positive left ventricular dP/dt in six of 11 patients. Peak positive left ventricular dP/dt was unchanged in four patients and reduced in one patient, all of whom experienced a substantial fall in left ventricular filling pressure. Thus milrinone has a definite inotropic effect in addition to its potent vasodilating properties.

摘要

联吡啶衍生物强大的血管舒张特性干扰了通过左心室dp/dt峰值来评估收缩性变化,这也解释了为何在心室功能不全患者中这些药物的正性肌力作用未能得到一致证实。因此,我们在心室充盈压同时发生变化的情况下,研究了静脉注射米力农对通过左心室dp/dt峰值测量的心肌收缩性的个体剂量反应效应。在11例患者中,有6例随着米力农剂量递增,左心室dp/dt峰值呈剂量相关增加。4例患者的左心室dp/dt峰值未变,1例患者的该峰值降低,所有这些患者的左心室充盈压均大幅下降。因此,米力农除具有强大的血管舒张特性外,还具有明确的正性肌力作用。

相似文献

1
Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure.米力农对重度心力衰竭患者左心室功能及心肌收缩力的影响。
Circulation. 1986 Mar;73(3 Pt 2):III162-7.
2
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.米力农和多巴酚丁胺用于严重心力衰竭:不同的血流动力学效应及个体患者反应性
Circulation. 1986 Mar;73(3 Pt 2):III175-83.
3
In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs.氨力农和米力农对戊巴比妥麻醉豚鼠左心室dp/dt、心室内压和心率的体内效应。
Res Commun Chem Pathol Pharmacol. 1991 Nov;74(2):237-40.
4
Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.米力农对重症充血性心力衰竭患者的正性肌力和血管舒张作用。剂量反应关系及与硝普钠的比较。
J Clin Invest. 1985 Feb;75(2):643-9. doi: 10.1172/JCI111742.
5
The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.当反射性肾上腺素能刺激被β-肾上腺素能阻滞剂抑制时,静脉注射米力农的变力性和血流动力学效应。
Clin Ther. 1994 Sep-Oct;16(5):783-92.
6
Acute effects of milrinone on the electrocardiogram and the cardiac hemodynamics of rats with pressure overload-induced congestive heart failure.
Arch Int Pharmacodyn Ther. 1989 Sep-Oct;301:182-99.
7
Pharmacology of the bipyridines: amrinone and milrinone.双吡啶类药物的药理学:氨力农和米力农。
Circulation. 1986 Mar;73(3 Pt 2):III10-24.
8
Milrinone versus dobutamine: contribution of altered myocardial mechanics and augmented inotropic state to improved left ventricular performance.米力农与多巴酚丁胺对比:心肌力学改变及正性肌力状态增强对左心室功能改善的作用
Circulation. 1986 Mar;73(3 Pt 2):III153-61.
9
Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.米力农治疗的充血性心力衰竭患者舒张功能指标的改善。
Circulation. 1984 Dec;70(6):1030-7. doi: 10.1161/01.cir.70.6.1030.
10
Myocardial actions of milrinone: characterization of its mechanism of action.
Circulation. 1986 Mar;73(3 Pt 2):III134-44.

引用本文的文献

1
Use of milrinone in cardiac surgical patients.米力农在心脏外科手术患者中的应用。
Cardiovasc Drugs Ther. 1993 Aug;7(4):671-5. doi: 10.1007/BF00877820.
2
Milrinone. A preliminary review of its pharmacological properties and therapeutic use.米力农。对其药理特性和治疗用途的初步综述。
Drugs. 1988 Aug;36(2):158-92. doi: 10.2165/00003495-198836020-00003.
3
The positive inotropic response to milrinone in isolated human and guinea pig myocardium.米力农对离体人心肌和豚鼠心肌的正性肌力反应。
Naunyn Schmiedebergs Arch Pharmacol. 1986 Oct;334(2):196-201. doi: 10.1007/BF00505822.
4
Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.新型强心剂对磷酸二酯酶的抑制作用:作用机制及其在充血性心力衰竭治疗中可能的临床意义
Klin Wochenschr. 1989 Jun 15;67(12):605-15. doi: 10.1007/BF01718141.
5
Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.充血性心力衰竭中不使用血管紧张素转换酶抑制剂的血管扩张剂治疗——效用与局限性
Cardiovasc Drugs Ther. 1989 Jun;3(3):375-96. doi: 10.1007/BF01858109.